Shopping Cart -

Your cart is currently empty.
Continue Shopping
This website use cookies and similar technologies to improve the site and to provide customised content and advertising. By using this site, you agree to this use. To learn more, including how to change your cookie settings, please view our Cookie Policy
Pocketmags Digital Magazines
Pocketmags Digital Magazines


Doctors are running out of EFFECTIVE DRUGS because of poor economic incentives to develop them

Medical researchers have known for decades that the pipeline for new drugs to stave of bacterial infections would one day run dry. That day is now at hand. In some cases, doctors have no drugs to give their patients for what once were treatable infections but are now life-threatening. Although researchers have many good leads, the bigger problem is a lack of financial incentives to bring new treatments through the drug-development gantlet. “When I signed up to be an infectious disease specialist 25 years ago, I never thought it would come to this,” says Helen Boucher, a physician at Tufts Medical Center in Boston and director of its infectious disease fellowship and heart transplant programs. Boucher has been a leading advocate for finding ways of investing in new treatments. She spoke with Newsweek about the drug-resistance problem and how we might dig our way out of it.

Purchase options below
Find the complete article and many more in this issue of Newsweek International - 31st May 2019
If you own the issue, Login to read the full article now.
Single Issue - 31st May 2019
Or 499 points
Annual Digital Subscription
Only $ 0.67 per issue
Or 3399 points
Monthly Digital Subscription
Only $ 0.94 per issue
Or 399 points

View Issues

About Newsweek International

Newsweek International - 31st May 2019